Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name MULTIVIR INC. Proposed Ticker MVIR CUSIP 62548C102 Business Description A clinical-stage gene therapy company developing a pipeline of novel product candidates for the treatment of multiple oncological indications. Lead Underwriter RBC Capital Markets, LLC Co-Managers Cantor Fitzgerald & Co., Nomura Securities International, Inc. Initial Shares 4,600,000 Revised Initial Shares N/A Initial Price $12.00-$14.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.